Evaluation of NanoDoce ® in Participants With Urothelial Carcinoma
Conditions: Bladder Cancer; Urothelial Carcinoma; Urinary Bladder Neoplasm; Urinary Bladder Cancer; Urogenital Neoplasms; Urologic Neoplasms; Urologic Cancer; Malignant Tumor of the Urinary Bladder; Cancer of the Bladder Interventions: Drug: NanoDoce (direct injection); Drug: NanoDoce (intravesical instillation); Other: Institutional Standard of Care Sponsors: NanOlogy, LLC; US Biotest, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Nanotechnology | Research | Urology & Nephrology